Human induced pluripotent stem cell-derived mesenchymal stem cells prevent adriamycin nephropathy in mice

Human induced pluripotent stem cell-derived mesenchymal stem cells (iPS-MSCs) are emerging as attractive options for use in cell replacement therapy, but their effect in kidney diseases remains unknown. Here, we showed that intravenous injection of iPS-MSCs protect against renal function loss in bot...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Hao Jia, Yiu, Wai Han, Wong, Dickson W.L., Li, Rui Xi, Chan, Loretta Y.Y., Leung, Joseph C.K., Zhang, Yuelin, Lian, Qizhou, Lai, Kar Neng, Tse, Hung Fat, Tang, Sydney C.W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5732756/
https://www.ncbi.nlm.nih.gov/pubmed/29262590
http://dx.doi.org/10.18632/oncotarget.21760

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5732756/
https://www.ncbi.nlm.nih.gov/pubmed/29262590
http://dx.doi.org/10.18632/oncotarget.21760

Ejemplares similares